DAY 1 - 360 min
|
| 08:45: |
WELCOME |
| 09:00: |
LIVE CASE #1 |
|
TAVI procedural planning from A to Z (MA/PG/RCT) part A
|
- 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. EuroIntervention 2024;20:e1-e10 • DOI: 10.4244/EIJ-D-23-00983
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395. Erratum in: Eur Heart J. 2022 Feb 18
- Management of Left-sided Severe VHD complicated by cardiogenic shock: focus on the role of transhcatheter valve interventions . A EAPCI clinical consensus statement in collaboration with the Association for Acute CardioVascular Care & the ESC Working Group on Cardiovascular Surgery. EuroIntervention 2023
|
| 1.1 |
Principles of THV selection |
| 1.2 |
MSCT imaging skills in TAVI |
| 1.3 |
TAVI primary vascular access planning according to anatomy. |
| 1.4 |
Challenging arterial access: the role of alternative access routes and of percutaneous interventions |
| 1.5 |
TAVI secondary vascular access planning. |
| 2.1 |
Procedural set-up |
| 2.2 |
Pharmacological strategies |
| 2.3 |
Large bore access |
| 2.4 |
Rapid pacing techniques |
| 2.5 |
Balloon aortic valvuloplasty (BAV) |
| 2.6 |
Technical considerations for THV deployment |
| |
| 11:30: |
LIVE CASE #2 |
|
TAVI complications management (HMG/RCT/EO)
|
- 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. EuroIntervention 2024;20:e1-e10 • DOI: 10.4244/EIJ-D-23-00983
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632.
- Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the EAPIC in collaboration with the ESC Council on Valvular Heart Disease.Eur Heart J. 2021 Jun 14;42(23):2265-2269
|
| 3.1 |
Preparation for complications: essential equipment, vascular and surgical access, team training |
| 3.2 |
Vascular access: pre-procedure assessment of access site selection, procedure performance, and use of closure devices. |
| 3.3 |
Endovascular management of vascular complications: perforation, dissection, and occlusion |
| 3.4 |
Management of bleeding complications: femoral, pericardial, and remote |
| 3.5 |
Conduction disorders: impact, prediction, prevention, management |
| 3.6 |
Valve malposition: migration, embolization or ectopic deployment |
| 3.7 |
Paravalvular regurgitation (PVL) peri-TAVI |
| 3.8 |
Coronary obstruction: prediction, risk-assessment, prevention, management |
| 3.9 |
Aortic injury: prediction, avoidance, and management of aortic dissection and annular rupture |
| 3.10 |
Acute hypotension: algorithm to identify cause of hypotension and acute management |
| 3.11 |
Stroke: risk evaluation, cerebral protection devices, acute management, clinical outcomes |
| 3.12 |
Patient prosthesis mismatch (PPM): prevention, diagnosis, outcomes |
| 15:00: |
LIVE IN THE BOX #1 (BAV) |
| 16:00: |
CLOSURE |
| |
DAY 2 - 360 min
|
| 09:00: |
LIVE CASE #3 |
|
TAVI procedural planning from A to Z (RCT/LR/EO)
|
- 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. EuroIntervention 2024;20:e1-e10 • DOI: 10.4244/EIJ-D-23-00983
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395. Erratum in: Eur Heart J. 2022 Feb 18
- Management of Left-sided Severe VHD complicated by cardiogenic shock: focus on the role of transhcatheter valve interventions . A EAPCI clinical consensus statement in collaboration with the Association for Acute CardioVascular Care & the ESC Working Group on Cardiovascular Surgery. EuroIntervention 2023
|
| 2.1 |
Procedural set-up |
| 2.2 |
Pharmacological strategies |
| 2.3 |
Large bore access |
| 2.4 |
Rapid pacing techniques |
| 2.5 |
Balloon aortic valvuloplasty (BAV) |
| 2.6 |
Technical considerations for THV deployment |
| |
| 11:30: |
LIVE CASE #4 |
|
Clinical case and Complications (HMG/RCT/TN)
|
- Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the EAPIC in collaboration with the ESC Council on Valvular Heart Disease.Eur Heart J. 2021 Jun 14;42(23):2265-2269
|
| 3.1 |
Preparation for complications: essential equipment, vascular and surgical access, team training |
| 3.2 |
Vascular access: pre-procedure assessment of access site selection, procedure performance, and use of closure devices. |
| 3.3 |
Endovascular management of vascular complications: perforation, dissection, and occlusion |
| 3.4 |
Management of bleeding complications: femoral, pericardial, and remote |
| 3.5 |
Conduction disorders: impact, prediction, prevention, management |
| 3.6 |
Valve malposition: migration, embolization or ectopic deployment |
| 3.7 |
Paravalvular regurgitation (PVL) peri-TAVI |
| 3.8 |
Coronary obstruction: prediction, risk-assessment, prevention, management |
| 3.9 |
Aortic injury: prediction, avoidance, and management of aortic dissection and annular rupture |
| 3.10 |
Acute hypotension: algorithm to identify cause of hypotension and acute management |
| 3.11 |
Stroke: risk evaluation, cerebral protection devices, acute management, clinical outcomes |
| 3.12 |
Patient prosthesis mismatch (PPM): prevention, diagnosis, outcomes |
| 15:00: |
LIVE IN THE BOX #2 (HOCM) |
| 16:00: |
CLOSURE |
| |
DAY 3 - 240 min
|
| 09:00: |
LIVE CASE #5 |
|
TAVI procedural planning from A to Z (RCT/SL/)
|
- 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. EuroIntervention 2024;20:e1-e10 • DOI: 10.4244/EIJ-D-23-00983
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395. Erratum in: Eur Heart J. 2022 Feb 18
- Management of Left-sided Severe VHD complicated by cardiogenic shock: focus on the role of transhcatheter valve interventions . A EAPCI clinical consensus statement in collaboration with the Association for Acute CardioVascular Care & the ESC Working Group on Cardiovascular Surgery. EuroIntervention 2023
|
| 4.1 |
Discharge from hospital: timing, planning, execution, and liaison with family |
| 4.2 |
Anti-thrombotic therapy after TAVI |
| 4.3 |
Clinical and imaging follow-up after TAVI: clinical review, imaging, endocarditis prevention, rehabilitation |
| 4.4 |
Bioprosthetic valve dysfunction (BVD): definitions, operative classification and outcomes. |
| 5.1 |
Low gradient AoS: low flow, normal flow, low EF, preserved EF |
| 5.2 |
TAVI and coronary artery disease (CAD) |
| 5.3 |
TAVI in bicuspid aortic valves |
| 5.4 |
TAVI for aortic regurgitation (AR) |
| 5.5 |
TAVI for valve in valve (VIV): TAVI in SAVR and TAVI in TAVI |
| 12:00: |
COURSE ASSESSMENT |
| 13:00: |
CLOSURE |
